Ani Pharmaceuticals (ANIP) Research & Development (2010 - 2026)
Ani Pharmaceuticals' Research & Development was $14.75 million in Q2 2026, down 10.8% from $16.54 million a year earlier but up 39.1% from the prior quarter.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Research & Development (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ani Pharmaceuticals' Research & Development was $49.91 million through Jun 30, 2026, down 7.4% year-over-year; for FY2025, it came in at $51.66 million, up 15.9% from FY2024.
- Research & Development has now increased for four consecutive years, with a five-year compound annual growth rate of 26.4% (FY2020 to FY2025).
- In earlier years, Research & Development was $44.58 million in FY2024 (+30.0%), $34.29 million in FY2023 (+53.6%), $22.32 million in FY2022 (+96.3%) and $11.37 million in FY2021 (-28.9%).
- Quarterly Research & Development has moved between $2.46 million (Q3 2021) and $16.65 million (Q4 2024) over five years.
- Compared with a year earlier, Research & Development was higher in five of the last eight quarters, with growth averaging 21.4%.
- The best year-over-year quarter for Research & Development over five years was Q3 2022 (growth of 211.8%); the worst was Q4 2025 (a decline of 26.3%).
- Per Business Quant data, ANIP's Research & Development in the three quarters before Q2 2026 was $10.6 million (Q1 2026), $12.26 million (Q4 2025) and $12.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,156.05 Bn | 1,124.64 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 624.19 Bn | 542.72 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 512.15 Bn | 485.26 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 365.34 Bn | 319.72 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.35 Bn | 261.34 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.44 Bn | 235.12 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 234.73 Bn | 190.13 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 193.00 Bn | 167.20 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.63 Bn | 118.27 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Ani Pharmaceuticals | 1.54 Bn | 320.19 Mn | 165.89 Mn | 14.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.75 Mn |
| Mar 31, 2026 | 10.60 Mn |
| Dec 31, 2025 | 12.26 Mn |
| Sep 30, 2025 | 12.30 Mn |
| Jun 30, 2025 | 16.54 Mn |
| Mar 31, 2025 | 10.56 Mn |
| Dec 31, 2024 | 16.65 Mn |
| Sep 30, 2024 | 10.13 Mn |
| Jun 30, 2024 | 7.30 Mn |
| Mar 31, 2024 | 10.51 Mn |
| Dec 31, 2023 | 9.87 Mn |
| Sep 30, 2023 | 11.12 Mn |
| Jun 30, 2023 | 7.37 Mn |
| Mar 31, 2023 | 5.92 Mn |
| Dec 31, 2022 | 5.22 Mn |
| Sep 30, 2022 | 7.66 Mn |
| Jun 30, 2022 | 4.17 Mn |
| Mar 31, 2022 | 5.27 Mn |
| Dec 31, 2021 | 3.14 Mn |
| Sep 30, 2021 | 2.46 Mn |
API Access
Ani Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ANIP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();